Heron Therapeuti (HRTX) stock news · rev $154.9M
Heron Therapeuti (HRTX) is a biotechnology company listed on US.
This HRTX news page leads with what Heron Therapeuti filed — not a scraped headline mill.
No cached 8-K sentence for HRTX yet. We will not pad this page with generic market recap.
Latest reported HRTX revenue for 2025-12-31 was $154.9M. Net income was -$20.2M. Revenue was up 7.4% from 2024-12-31 to 2025-12-31. HRTX currently screens at market cap $332.6M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the HRTX stock page; for the tape open the quote page.
HRTX stock news FAQ
What are HRTX's latest revenue and net income?
Latest cached Heron Therapeuti (HRTX) revenue for Dec 31, 2025 was $154.9M. Net income was -$20.2M. Statements: https://lician.com/financials/hrtx
How did HRTX revenue change from the prior cached period?
Cached Heron Therapeuti (HRTX) revenue was up 7.4% from $144.3M (Dec 31, 2024) to $154.9M (Dec 31, 2025). Statements: https://lician.com/financials/hrtx
What is HRTX's market cap?
Heron Therapeuti (HRTX) market cap is $332.6M on the latest cached fundamentals snapshot.
What kind of company is HRTX?
Heron Therapeuti (HRTX) is a biotechnology company listed on US.
Where is HRTX stock news listed?
Cached stock news for Heron Therapeuti (HRTX) is listed at https://lician.com/news/hrtx. Filings: https://lician.com/sec/hrtx
Not investment advice.